Unknown

Dataset Information

0

Why should we use convalescent plasma for COVID-19?

ABSTRACT:

SUBMITTER: Franchini M 

PROVIDER: S-EPMC7229974 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Why should we use convalescent plasma for COVID-19?

Franchini Massimo M  

European journal of internal medicine 20200516

Similar Datasets

Unknown Use of convalescent plasma in COVID-19 patients with immunosuppression.
| S-EPMC8242637 | biostudies-literature
Unknown Use of Outpatient-Derived COVID-19 Convalescent Plasma in COVID-19 Patients Before Seroconversion.
| S-EPMC8477649 | biostudies-literature
Unknown Autoantibodies in COVID-19 convalescent plasma donors.
| S-EPMC12803771 | biostudies-literature
Unknown Functional Antibodies in COVID-19 Convalescent Plasma.
| S-EPMC7987034 | biostudies-literature
Unknown How should we use convalescent plasma therapies for the management of COVID-19?
| S-EPMC7992504 | biostudies-literature
Unknown International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Responses.
| S-EPMC8242651 | biostudies-literature
Unknown Convalescent plasma use in the USA was inversely correlated with COVID-19 mortality.
| S-EPMC8205484 | biostudies-literature
Unknown Heterogeneity in COVID-19 Convalescent Plasma Clinical Trials.
| S-EPMC8426852 | biostudies-literature
Unknown COVID-19, Hypercoagulability, and Cautiousness with Convalescent Plasma.
| S-EPMC7874424 | biostudies-literature
Unknown COVID-19 Convalescent Plasma Therapy: Long-term Implications.
| S-EPMC10807994 | biostudies-literature